bpc 157 clinical trials bpc-157 trial studies safety Here's a nice graphic on that you can hand out Peptide BPC-157 - Does It

Specificity is not the same as safety

Repeat the recommended dose 1 or 2 times a week for 4 to 6 weeks

weight loss (Phase 2/3 peak) | ~15% | ~22% | ~24% | | FDA Status | Approved (Wegovy, Ozempic) | Approved (Zepbound, Mounjaro) | Phase 3 (2026) | | Dosing frequency | Weekly | Weekly | Weekly | The additional glucagon receptor agonism is believed to be responsible for retatrutide's greater metabolic rate increase and enhanced fat oxidation compared to dual agonists

It is sold legally as a research chemical

Insert the needle at a 90-degree angle into the muscle

Only pre-filled injection pens (Mounjaro and Zepbound) manufactured by Eli Lilly are approved, as compounded or reconstituted powder forms carry risks of contamination, dosing errors, and unknown ingredient stability